AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis

2015 ◽  
Vol 69 (3) ◽  
pp. 215-220 ◽  
Author(s):  
Qianshan Ding ◽  
Jian Kang ◽  
Jinfen Dai ◽  
Meng Tang ◽  
Qi Wang ◽  
...  
Keyword(s):  
Heptocellular Carcinoma

Proteome analysis of a human heptocellular carcinoma cell line, HCC-M: An update

2001 ◽  
Vol 22 (13) ◽  
pp. 2804-2811 ◽  
Author(s):  
Keli Ou ◽  
Teck Keong Seow ◽  
Rosa C. M. Y. Liang ◽  
Shao-En Ong ◽  
Maxey C. M. Chung
Keyword(s):  
Cell Line ◽  
Carcinoma Cell ◽  
Proteome Analysis ◽  
Carcinoma Cell Line ◽  
Heptocellular Carcinoma

Fine needle liver biopsy of heptocellular carcinoma: Is sampling simple?

1989 ◽  
Vol 97 (1) ◽  
pp. 247-248 ◽  
Author(s):  
Maurizio D'Aquino ◽  
Lucio Michieletto ◽  
Luciano Caprioglio ◽  
Paolo Wolf
Keyword(s):  
Liver Biopsy ◽  
Fine Needle ◽  
Heptocellular Carcinoma ◽  
Needle Liver Biopsy

Early Diagnosis of Hepatocellular Carcinoma in Haemochromatosis Influences Surgical Management

1998 ◽  
Vol 43 (4) ◽  
pp. 114-115 ◽  
Author(s):  
H. Pleass ◽  
O.J. Garden
Keyword(s):  
Hepatocellular Carcinoma ◽  
Early Diagnosis ◽  
Retrospective Analysis ◽  
Median Survival ◽  
Case Note ◽  
Time Interval ◽  
Right Hepatectomy ◽  
Heptocellular Carcinoma ◽  
Mean Time ◽  
Case Note Review

Using case note review, a retrospective analysis was carried out of all patients referred with haemochromatosis and suspected hepatocelluclar carcinoma between 1988 and 1997 to define the mode of presentation, management and outcome of such patients. All 12 patients were male with a mean age of 67 years. Four patients presented whilst asymptomatic by alpha-fetoprotein screening. Mean time interval between diagnosis of haemochromatosis and heptocellular carcinoma was 6.7 years. One patient underwent right hepatectomy, seven patients were treated by chemoembolisation and the remaining four patients were treated symptomatically. The median survival of the chemoembolised patients was 13 months. Of those patients treated symptomatically, the median survival was four months. Screening for hepatocellular carcinoma is often not undertaken inpatients with haemochromatosis. Survival prospects are poor in patients whose tumour presents symptomatically.

A Novel Replication-competent Adenovirus CNHK500 in the Treatment of Heptocellular Carcinoma In Vitro

2004 ◽  
Vol 3 (2) ◽  
Author(s):  
Qijun Qian ◽  
Qi Zhang ◽  
Mengchao Wu ◽  
Linhui Peng ◽  
Yueming LI
Keyword(s):  
Heptocellular Carcinoma
Sign in / Sign up

Export Citation Format

Share Document